ResearchMoz added Latest Research Report titled " Global Colorectal Cancer Market: Industry Analysis & Outlook (2021-2025) " to it's Large Report database.
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that has the ability to invade or spread to other parts of the body. Signs and symptoms for this cancer may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time. The current screening regime for this disease comprises of gFOBT, FIT, flexible Sigmoidoscopy, Colonoscopy and others. Further, the treatment for CRC is limited to surgery, chemotherapy and radiotherapy or adjuvant therapies.
The global CRC market would be driven by factors such as rising geriatric population, better reimbursement policies, growing number of obese people and others. However, the dynamics such as stringent regulatory norms, side effects of therapies and high cost of screening tests or drugs are expected to act as a threat for market’s growth. Rising awareness regarding the incidence of CRC and importance of diagnosis has propelled higher compliance with regular tests. Further, in order to harness the market potential, various companies are involved in developing lesser invasive and easy to use screening methods.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1311255
The report “Global Colorectal Cancer Market: Industry Analysis & Outlook (2021-2025)” provides a comprehensive study of global market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in-depth. The global market is highly competitive consisting of several large enterprises including Bayer AG, Roche Holding AG, Merck & Co., Inc. and Eli Lilly and Company. The competitive landscape of the respective market, along with the company profiles of leading players are discussed in detail.
Table of Content
1. Overview
1.1 Colorectal Cancer
1.2 Signs, Symptoms and Stages
1.3 Diagnosis
1.4 Treatment
Browse more details @ http://www.researchmoz.us/global-colorectal-cancer-market-industry-analysis-outlook-20212025-report.html
2. Global Colorectal Cancer Market
2.1 Global Cancer Diagnostics Market Forecast by Value
2.2 Global CRC Screening Patient Volume Forecast
2.3 Global CRC Screening Patient Volume by Region
2.4 Global CRC Screening Product Market
2.4.1 Global C-Scan Cap Revenue Forecast
2.5 Global CRC Patients on Drugs by Volume
2.6 Global CRC Patients on Drugs by Region
2.7 Global CRC Patients on Drugs by Segments
2.8 Global CRC Drug Market
2.8.1 Global Modufolin Revenue Forecast
2.8.2 Global Modufolin Revenue Forecast by Segments
2.8.3 Global Modufolin Revenue as First Line Drug
2.8.4 Global Modufolin Revenue as Second Line Drug
2.8.5 Global Modufolin Revenue as Third Line Drug
3. Regional Market
3.1 The US
3.1.1 The US CRC Screening Patient Volume Forecast
3.1.2 The US CRC Screening Volume by Test Mix
3.1.3 The US C-Scan Cap Revenue Forecast
3.1.4 The US Patients on First Line CRC Drug by Volume
3.1.5 The US Patients on Second Line CRC Drug by Volume
3.1.6 The US Patients on Third Line CRC Drug by Volume
3.2 Europe
3.2.1 Europe CRC Screening Patient Volume Forecast
3.2.2 Europe C-Scan Cap Revenue Forecast
3.2.3 Europe Patients on First Line CRC Drug by Volume
3.2.4 Europe Patients on Second Line CRC Drug by Volume
3.2.5 Europe Patients on Third Line CRC Drug by Volume
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that has the ability to invade or spread to other parts of the body. Signs and symptoms for this cancer may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time. The current screening regime for this disease comprises of gFOBT, FIT, flexible Sigmoidoscopy, Colonoscopy and others. Further, the treatment for CRC is limited to surgery, chemotherapy and radiotherapy or adjuvant therapies.
The global CRC market would be driven by factors such as rising geriatric population, better reimbursement policies, growing number of obese people and others. However, the dynamics such as stringent regulatory norms, side effects of therapies and high cost of screening tests or drugs are expected to act as a threat for market’s growth. Rising awareness regarding the incidence of CRC and importance of diagnosis has propelled higher compliance with regular tests. Further, in order to harness the market potential, various companies are involved in developing lesser invasive and easy to use screening methods.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1311255
The report “Global Colorectal Cancer Market: Industry Analysis & Outlook (2021-2025)” provides a comprehensive study of global market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in-depth. The global market is highly competitive consisting of several large enterprises including Bayer AG, Roche Holding AG, Merck & Co., Inc. and Eli Lilly and Company. The competitive landscape of the respective market, along with the company profiles of leading players are discussed in detail.
Table of Content
1. Overview
1.1 Colorectal Cancer
1.2 Signs, Symptoms and Stages
1.3 Diagnosis
1.4 Treatment
Browse more details @ http://www.researchmoz.us/global-colorectal-cancer-market-industry-analysis-outlook-20212025-report.html
2. Global Colorectal Cancer Market
2.1 Global Cancer Diagnostics Market Forecast by Value
2.2 Global CRC Screening Patient Volume Forecast
2.3 Global CRC Screening Patient Volume by Region
2.4 Global CRC Screening Product Market
2.4.1 Global C-Scan Cap Revenue Forecast
2.5 Global CRC Patients on Drugs by Volume
2.6 Global CRC Patients on Drugs by Region
2.7 Global CRC Patients on Drugs by Segments
2.8 Global CRC Drug Market
2.8.1 Global Modufolin Revenue Forecast
2.8.2 Global Modufolin Revenue Forecast by Segments
2.8.3 Global Modufolin Revenue as First Line Drug
2.8.4 Global Modufolin Revenue as Second Line Drug
2.8.5 Global Modufolin Revenue as Third Line Drug
3. Regional Market
3.1 The US
3.1.1 The US CRC Screening Patient Volume Forecast
3.1.2 The US CRC Screening Volume by Test Mix
3.1.3 The US C-Scan Cap Revenue Forecast
3.1.4 The US Patients on First Line CRC Drug by Volume
3.1.5 The US Patients on Second Line CRC Drug by Volume
3.1.6 The US Patients on Third Line CRC Drug by Volume
3.2 Europe
3.2.1 Europe CRC Screening Patient Volume Forecast
3.2.2 Europe C-Scan Cap Revenue Forecast
3.2.3 Europe Patients on First Line CRC Drug by Volume
3.2.4 Europe Patients on Second Line CRC Drug by Volume
3.2.5 Europe Patients on Third Line CRC Drug by Volume
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
No comments:
Post a Comment